Login

Consolidated Balance Sheets

In millions of USD; shares in millions, except per-share amounts
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
ASSETS
Current assets:
Cash and cash equivalents
Restricted cash
Short-term investments, available-for-sale
Accounts receivable
Inventory
Prepaid expenses and other current assets
Current assets from discontinued operations
Total current assets
Property and equipment, net
Finance lease right-of-use asset, net
Operating lease right-of-use asset
Long-term investments, available-for-sale
Other assets
Noncurrent assets from discontinued operations
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accrued liabilities
Accrued indirect tax liabilities
Accrued compensation and benefits
Current portion of term loan
Current contract liabilities
Current portion of finance lease liability
Current portion of operating lease liability
Current liabilities from discontinued operations
Total current liabilities
Long-term contract liabilities
Long-term finance lease liability
Long-term operating lease liability
Noncurrent liabilities from discontinued operations
Total liabilities
Stockholders’ equity:
Preferred stock
Common stock, $0.0001 par value; 100,000,000 shares authorized at September 30, 2025 and 50,000,000 shares authorized at December 31, 2024; 29,335,397 shares issued and outstanding at September 30, 2025 and 10,946,635 shares issued and outstanding at December 31, 2024
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity
Preferred stock, shares authorized (in shares)
Series A Convertible Preferred Stock
Series X Convertible Preferred Stock
Total preferred stock, shares authorized (in shares)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support